Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
Background: The association between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) has been suggested previously, but prior studies provided contradicting findings. Objectives: To characterize the expression profile of eight classic and non-classic aPL in patients diagnosed with MS. M...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2015
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22196
- Acceso en línea:
- https://repository.urosario.edu.co/handle/10336/22196
- Palabra clave:
- Beta2 glycoprotein 1
Cardiolipin antibody
Immunoglobulin g
Immunoglobulin m
Phosphatidylethanolamine
Phosphatidylserine
Phospholipid antibody
Prothrombin
Prothrombin complex
Immunoglobulin g
Immunoglobulin m
Phospholipid antibody
Adult
Antibody titer
Article
Controlled study
Disease duration
Female
Flow cytometry
Fluorescence analysis
Human
Immunoassay
Major clinical study
Male
Middle aged
Multiple sclerosis
Protein expression
Blood
Case control study
Cross-sectional study
Immunology
Multiple sclerosis
Prevalence
Adult
Case-control studies
Cross-sectional studies
Female
Humans
Immunoglobulin g
Immunoglobulin m
Male
Middle aged
Multiple sclerosis
Prevalence
Antiphospholipid syndrome (aps)
Autoantibodies
Autoimmunity
Beta 2-glycoprotein 1 (?2gpi)
Cardiolipin
Immunoglobulin (ig)
Multiple sclerosis (ms)
antiphospholipid
Antibodies
- Rights
- License
- Abierto (Texto Completo)
Summary: | Background: The association between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) has been suggested previously, but prior studies provided contradicting findings. Objectives: To characterize the expression profile of eight classic and non-classic aPL in patients diagnosed with MS. Methods: Using the BioPlex™ 2200 immunoassay, we measured the levels of serum immunoglobulin (Ig)M and IgG isotypes of three classic aPL and five non-classic aPL in 98 subjects with MS and 237 healthy controls. Results: Three non-classic aPL were significantly more prevalent among MS patients in comparison to the control group. These antibodies included IgM and IgG against phosphatidylserine- ?2GPI (PS-B2), IgG prothrombin complex (PT-PT) and IgM prothrombin (PT). The positive results according to Bonferroni correction are PS-B2 IgG and PT-PT IgG. The remaining aPL profiles did not differ significantly between the two groups. Conclusions: An association between certain non-classic aPL and MS has been established. The specific role of these autoantibodies in the pathogenesis of the condition remains uncertain. © 2015, Israel Medical Association. All rights reserved. |
---|